Scott & Selber Inc. Has $2.57 Million Holdings in The Clorox Company $CLX

Scott & Selber Inc. lifted its stake in The Clorox Company (NYSE:CLX) by 47.2% in the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 24,839 shares of the company’s stock after buying an additional 7,964 shares during the period. Scott & Selber Inc.’s holdings in Clorox were worth $2,574,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Wilkins Investment Counsel Inc. raised its position in Clorox by 250.6% in the 4th quarter. Wilkins Investment Counsel Inc. now owns 55,064 shares of the company’s stock valued at $5,552,000 after purchasing an additional 39,360 shares during the last quarter. JPMorgan Chase & Co. boosted its stake in shares of Clorox by 27.0% in the 3rd quarter. JPMorgan Chase & Co. now owns 928,654 shares of the company’s stock valued at $114,506,000 after purchasing an additional 197,330 shares during the last quarter. Morningstar Investment Management LLC raised its position in shares of Clorox by 131.8% during the 4th quarter. Morningstar Investment Management LLC now owns 62,454 shares of the company’s stock valued at $6,297,000 after acquiring an additional 35,506 shares during the last quarter. Swiss Life Asset Management Ltd increased its holdings in Clorox by 221.4% in the third quarter. Swiss Life Asset Management Ltd now owns 86,426 shares of the company’s stock valued at $10,656,000 after purchasing an additional 59,533 shares during the last quarter. Finally, Birch Hill Investment Advisors LLC bought a new stake in shares of Clorox in the 4th quarter valued at about $22,103,000. Institutional investors own 78.53% of the company’s stock.

Clorox Stock Performance

CLX stock opened at $95.90 on Monday. The Clorox Company has a 1-year low of $84.70 and a 1-year high of $132.03. The company has a current ratio of 0.84, a quick ratio of 0.65 and a debt-to-equity ratio of 27.03. The stock has a 50-day moving average price of $95.71 and a 200-day moving average price of $104.81. The firm has a market cap of $11.60 billion, a PE ratio of 15.57, a price-to-earnings-growth ratio of 0.50 and a beta of 0.56.

Clorox (NYSE:CLX) last issued its earnings results on Thursday, April 30th. The company reported $1.64 EPS for the quarter, beating analysts’ consensus estimates of $1.55 by $0.09. Clorox had a return on equity of 443.64% and a net margin of 11.18%.The business had revenue of $1.67 billion during the quarter, compared to analyst estimates of $1.67 billion. During the same period in the previous year, the company posted $1.45 EPS. The firm’s revenue was up .1% compared to the same quarter last year. Clorox has set its FY 2026 guidance at 5.450-5.650 EPS. As a group, equities research analysts expect that The Clorox Company will post 5.61 earnings per share for the current year.

Insider Transactions at Clorox

In related news, Director Pierre R. Breber acquired 5,000 shares of the firm’s stock in a transaction that occurred on Tuesday, May 5th. The stock was acquired at an average price of $85.82 per share, for a total transaction of $429,100.00. Following the completion of the acquisition, the director owned 18,000 shares of the company’s stock, valued at approximately $1,544,760. This represents a 38.46% increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. 0.63% of the stock is owned by company insiders.

Analyst Upgrades and Downgrades

A number of analysts have recently issued reports on CLX shares. JPMorgan Chase & Co. lowered their price objective on shares of Clorox from $99.00 to $95.00 and set an “underweight” rating on the stock in a report on Friday, May 1st. The Goldman Sachs Group reiterated a “sell” rating and issued a $83.00 price objective on shares of Clorox in a report on Friday, May 1st. BNP Paribas Exane lowered their target price on Clorox from $128.00 to $97.00 and set a “neutral” rating on the stock in a research note on Tuesday, May 12th. Deutsche Bank Aktiengesellschaft reaffirmed a “hold” rating and set a $91.00 price target on shares of Clorox in a research report on Friday, May 1st. Finally, Jefferies Financial Group dropped their price objective on Clorox from $139.00 to $125.00 and set a “buy” rating for the company in a report on Monday, May 4th. One analyst has rated the stock with a Buy rating, eleven have assigned a Hold rating and five have given a Sell rating to the company. According to data from MarketBeat, the company has an average rating of “Reduce” and an average target price of $103.40.

Clorox Profile

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.